A 19-year-old cisgender man started taking daily oral tenofovir DF-emtricitabine for preexposure prophylaxis (PrEP) 18 months ago. For the past 3 months, he has been taking the HIV PrEP medication intermittently. Laboratory studies from a follow-up visit 2 days prior showed a reactive HIV-1/2 antigen-antibody immunoassay test; HIV-1 infection was confirmed with the HIV-1/2 differentiation assay. A quantitative HIV RNA level is pending. He is immediately referred to a clinic that provides comprehensive HIV clinical care and is seen in the new clinic 2 days later.
Which one of the following would you recommend as the next step in managing this person newly diagnosed with HIV?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 20th, 2023
September 20th, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5